Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-20-035491
Date:2020-03-16
Issuer: RA PHARMACEUTICALS, INC. (RARX)
Original Submission Date:

Reporting Person:

FARZANEH-FAR RAMIN
C/O RA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-03-16 M 1,389 a $5.60 8,521 direct
COMMON STOCK 2020-03-16 M 9,206 a $5.60 17,727 direct
COMMON STOCK 2020-03-16 S 10,595 d $45.16 7,132 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 5.6 2020-03-16 deemed execution date M 1,389 (d) 2026-08-16 common stock 1,389 $5.60 11,110 direct
STOCK OPTIONS (RIGHT TO BUY) 5.6 2020-03-16 deemed execution date M 9,206 (d) 2026-08-16 common stock 9,206 $5.60 73,654 direct
Footnotes
IDfootnote
f1 the sale reported in the form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 16, 2019.
f2 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $44.85 to $45.82. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 these stock options vest over a four (4) year period in 48 equal monthly installments at the end of each month following august 16, 2016.
f4 these stock options vest a four (4) year period with the first twenty five percent (25%) of such shares vesting on the first anniversary of july 11, 2016, and the remaining shares vesting in equal monthly installments at the end of each month following the first anniversary of july 11, 2016 over the following thirty six (36) months, subject to the terms set forth in the applicable equity agreement.
WhaleWisdom Logo

Elevate your investments